Objective: To present the experience of managing myomatosis with selective arterial embolization. Material and methods: Observational, cross-sectional, descriptive and prospective study during the period January 2015-December 2019, in patients undergoing selective arterial embolization as a treatment for myomatosis. Clinical characteristics and outcomes of interest were recorded for statistical analysis (age, symptoms, type of fibroids, imaging characteristics, changes in size and severity of symptoms at 6 months). Results: The most frequent clinical manifestations were hyperpolymenorrhea (40.9%), anemia (13.6%), infertility (9.1%) and dyspareunia (9.1%). 68.2% of the fibroids were FIGO 2 (submucosal > 50% intramural), 22.7% FIGO 1 (submucosal <50% intramural) and 9.1% FIGO 5 (subserous > 50% intramural). By T2-weighted MRI, 4.5% were classified as isointense, 9.1% hyperintense, 68.2% heterogeneous, mostly hypointense (hyaline degeneration), and 18.2% heterogeneous mostly hyperintense (cystic degeneration). At 6 months, in 2 patients the size was reduced by 95%, 75% in three, 50% in 16 and 25%. The rate of successful procedures was 95.5% and the intensity of symptoms decreased in all patients more than 90%. Conclusions: The myomatosis was successfully treated with selective arterial embolization, the size of the fibroids and the associated symptoms were reduced.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.